149 related articles for article (PubMed ID: 26845432)
21. Differential Expression of MicroRNA-19b Promotes Proliferation of Cancer Stem Cells by Regulating the TSC1/mTOR Signaling Pathway in Multiple Myeloma.
Wang N; Liang X; Yu W; Zhou S; Fang M
Cell Physiol Biochem; 2018; 50(5):1804-1814. PubMed ID: 30396185
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Pichiorri F; Suh SS; Ladetto M; Kuehl M; Palumbo T; Drandi D; Taccioli C; Zanesi N; Alder H; Hagan JP; Munker R; Volinia S; Boccadoro M; Garzon R; Palumbo A; Aqeilan RI; Croce CM
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12885-90. PubMed ID: 18728182
[TBL] [Abstract][Full Text] [Related]
23. miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3.
Lu Y; Wu D; Wang J; Li Y; Chai X; Kang Q
Biochem Biophys Res Commun; 2016 May; 473(4):1315-1320. PubMed ID: 27086852
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
[TBL] [Abstract][Full Text] [Related]
25. miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4.
Wu Y; Zhu X; Shen R; Huang J; Xu X; He S
Pathol Res Pract; 2019 Nov; 215(11):152603. PubMed ID: 31540771
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA H19 promotes vincristine resistance in multiple myeloma by targeting Akt.
Wang Y; Xu S; Wang L; Liu J; Wang J; Zhou J
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):76-80. PubMed ID: 33040789
[TBL] [Abstract][Full Text] [Related]
28. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
29. Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression.
Gowda PS; Wildman BJ; Trotter TN; Xu X; Hao X; Hassan MQ; Yang Y
Mol Cancer Res; 2018 Jul; 16(7):1138-1148. PubMed ID: 29592898
[TBL] [Abstract][Full Text] [Related]
30. MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt.
Ru N; Zhang F; Liang J; Du Y; Wu W; Wang F; Liu X
Gene; 2018 Mar; 645():163-169. PubMed ID: 29248580
[TBL] [Abstract][Full Text] [Related]
31. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
34. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
[TBL] [Abstract][Full Text] [Related]
35. miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.
De Luca T; Pelosi A; Trisciuoglio D; D'Aguanno S; Desideri M; Farini V; Di Martile M; Bellei B; Tupone MG; Candiloro A; Regazzo G; Rizzo MG; Del Bufalo D
Mol Carcinog; 2016 Dec; 55(12):2304-2312. PubMed ID: 26599548
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway.
Xu Z; Huang C; Hao D
Oncol Rep; 2017 Feb; 37(2):1261-1269. PubMed ID: 27959416
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
Que W; Chen J; Chuang M; Jiang D
APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-206 Reduces Osteosarcoma Cell Malignancy
Zhan FB; Zhang XW; Feng SL; Cheng J; Zhang Y; Li B; Xie LZ; Deng QR
Yonsei Med J; 2019 Feb; 60(2):163-173. PubMed ID: 30666838
[TBL] [Abstract][Full Text] [Related]
39. LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway.
Wu Y; Wang H
J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29205703
[TBL] [Abstract][Full Text] [Related]
40.
Long ZH; Bai ZG; Song JN; Zheng Z; Li J; Zhang J; Cai J; Yao HW; Wang J; Yang YC; Yin J; Zhang ZT
Anticancer Res; 2017 Aug; 37(8):4345-4352. PubMed ID: 28739727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]